New patent expiration for Abbvie drug DALVANCE
Annual Drug Patent Expirations for DALVANCE Dalvance is a drug marketed by Abbvie and is included in one NDA. It […]
Annual Drug Patent Expirations for DALVANCE Dalvance is a drug marketed by Abbvie and is included in one NDA. It […]
Annual Drug Patent Expirations for KYLEENA Kyleena is a drug marketed by Bayer Hlthcare and is included in one NDA.
New patent expiration for Bayer Hlthcare drug KYLEENA Read Post »
Annual Drug Patent Expirations for SKYLA Skyla is a drug marketed by Bayer Hlthcare and is included in one NDA.
New patent expiration for Bayer Hlthcare drug SKYLA Read Post »
AMRIX (cyclobenzaprine hydrochloride) Teva pharms intl Patent: 7,829,121 Expiration: Nov 14, 2023 See More … For more information on how
Drug Patent Expirations for the Week of November 12, 2023 Read Post »
AMRIX (cyclobenzaprine hydrochloride) Teva pharms intl Patent: 7,829,121 Expiration: Nov 14, 2023 See More … For more information on how
Drug Patent Expirations for the Week of November 12, 2023 Read Post »
Annual Drug Patent Expirations for STIOLTO+RESPIMAT Stiolto Respimat is a drug marketed by Boehringer Ingelheim and is included in one
New patent expiration for Boehringer Ingelheim drug STIOLTO RESPIMAT Read Post »
Annual Drug Patent Expirations for STRIVERDI+RESPIMAT Striverdi Respimat is a drug marketed by Boehringer Ingelheim and is included in one
New patent expiration for Boehringer Ingelheim drug STRIVERDI RESPIMAT Read Post »
Annual Drug Patent Expirations for XEPI Xepi is a drug marketed by Ferrer Internacional and is included in one NDA.
New patent expiration for Ferrer Internacional drug XEPI Read Post »
Annual Drug Patent Expirations for LONHALA+MAGNAIR+KIT Lonhala Magnair Kit is a drug marketed by Sumitomo Pharma Am and is included
New patent expiration for Sumitomo Pharma drug LONHALA MAGNAIR KIT Read Post »
Get fresh news and insights, drug patent expirations & more…